OSCR - CIK 0001568651
The table below shows Oscar Health, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $2.62B | $878.54M | $634.36M | $414.71M | $562.85M | $317.69M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$590.25M | -$174.23M | -$300.59M | $135.51M | $102.81M | -$34.28M |
| Dividends paid | - | - | - | - | - |
Oscar Health, Inc. reported operating cash flow of $1.09B for fiscal year 2025. That is up 11.9% from $978.19M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow grew from -$165.37M (FY 2019) to $1.09B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$3.60M | $4.87M | $27.31M | $506.00K | $298.77M | $1.21B |